Insurance premium growth forecast in real terms...
Category:
Non-Life
Latest
Centre issues advisory on air pollution
Air quality has worsened in several cities, including Mumbai,...
Cyber Insurance: Largest potential lies in the SME opportunity, says Swiss Re
Dani Tobler.Head Cyber Reinsurance at Swiss Re "North America...
India to add 100 more earthquake observatories by 2026: Jitendra Singh
He impressed upon India’s commitment to supporting various projects of earth system science to quantify the seismic hazard for better land use and urban planning and creating disaster-resilient infrastructures for reducing risks and ultimately paving the way to sustainable development.
July non-life insurance premiums shrug off pandemic cloud: Care Ratings
Non-life insurance premium reached Rs 20,171 crore compared to Rs 16,885 crore in July 2020. The growth was driven by health and fire segments with motor segment also turning in positive numbers.
Has global automobile market revived?
By market, India market showed the largest increase of 95.2 per cent year-on-year. It was followed by Russia (38.2 per cent |), the US (29.3 per cent |), China (27.5 per cent |), Europe (27.1 per cent |), Brazil (26.3 per cent |), and Mexico (18.1 per cent |). Compared to the first half of 2019 before COVID-19, India (1.5 per cent |) and Russia (6.0 per cent |) showed positive growth rate. The U.S. (1.3 per cent |) and China (1.1 per cent |) also showed similar level before COVID-19. However, Brazil (24.6 per cent |), Europe (23.0 per cent |), and Mexico (19.6 per cent |) showed relatively slow recovery.
J&J seeks nod for COVID-19 vaccine trial in Indian adolescents
Conducting vaccine clinical trials among adolescents is imperative to achieve herd immunity against the coronavirus, J&J said in an emailed statement.
The U.S. pharma giant had received emergency use approval for its single-dose vaccine in India earlier this month, making it the fifth authorised vaccine in the country. read more
Japanese general insurance industry to reach $133.1bn in 2025, forecasts GlobalData
Motor insurance is the largest segment in the Japanese general insurance industry with 51.5% of GWP in 2020. It is forecasted to grow by 1.4% in 2021 against the decline of -3.6% in 2020, backed by improved vehicle sales. According to the Japan Auto Manufacture Association (JAMA), new vehicle registrations during January-April 2021 increased by 4.2% as compared to same period in 2020.
The segment is expected to grow at a CAGR of 1.7% during 2020-2025. The launch of fully autonomous vehicles targeting local and global markets as well as expansion of electric car market is expected to drive growth of the motor insurance segment during the forecast period
FDI proposal for bank-promoted insurance firm to be vetted by RBI, Irdai: Govt notification
”Applications for foreign direct investment in private banks having joint venture or subsidiary in insurance sector may be addressed to the Reserve Bank for consideration in consultation with the Insurance Regulatory and Development Authority of India (IRDAI), in order to ensure that the limit of foreign investment applicable for the insurance sector as specified in serial number F. 8.1 and F. 8.2 is not breached,” the notification said.
India approves Zydus Cadila’s ZyCoV-D vaccine for emergency use for adults and children above 12 yrs
Chairperson of the Zydus Group, Pankaj R Patel said, “We are extremely happy that our efforts to put out a safe, well-tolerated and efficacious vaccine to fight COVID-19 has become a reality with ZyCoV-D. To create the world’s first DNA vaccine at such a crucial juncture and despite all the challenges, is a tribute to the Indian research scientists and their spirit of innovation. I’d like to thank the Department of Biotechnology under the Government of India for their support in this mission of Atma Nirbhar Bharat and Indian Vaccine Mission COVID Suraksha.”
Tokio Marine Insurance hit by ransomware attack in Singapore
“At this time, we can confirm that there is no indication of a breach of any customer information nor confidential information of the group, We have appointed an external specialized vendor to perform a third-party analysis of the systems to verify scope of impact,”” said the group in the statement.
UK court sets scene for $14 bln-plus class action against MastercardL
Merricks alleges Mastercard charged excessive “interchange” fees – the fees retailers pay credit card companies when consumers use a card to shop – between May 1992 and June 2008 and that those fees were passed on to consumers as retailers raised prices.
Report about fake Covishield vaccine being probed: Mandaviya
”It has been claimed that duplicate versions of Covishield vaccine were sold in the country. The Indian government is probing this claim, and will take action if it found any substance to the allegations,” he told reporters in Rajkot.